M&M Revises Erkunt Traktor Sale Terms; MOICML to Infuse ~₹471 Crore to Clear Debt
Mahindra & Mahindra revised the infusion terms for the divestment of its stake in Erkunt Traktor, with MOICML increasing its infusion to Turkish Lira 2.26 billion (~₹471 crore) to extinguish external debt. Buyers Hisarlar, Sahinkaya, and Sarioglu will additionally infuse USD 10 million (~₹95 crore), while the seller consideration remains unchanged at Turkish Lira 1,00,000 (~Rs. 2,13,000). The transaction is expected to close by August 15, 2026.

*this image is generated using AI for illustrative purposes only.
Mahindra & Mahindra has revised the infusion terms for the divestment of its entire stake in step-down subsidiary Erkunt Traktor Sanayii Anonim Şirketi. The company informed the exchanges on June 30, 2026, that the infusion amount was increased to Turkish Lira 2.26 billion (~₹471 crore) to extinguish external debt and fund the business until the transaction closes. The deal is expected to be completed by August 15, 2026.
The amendment involves Mahindra Overseas Investment Company (Mauritius) Limited (MOICML), a wholly owned subsidiary, and its subsidiary Erkunt Traktor. The buyers are Hisarlar Makina Sanayi ve Ticaret A.Ş., Mr. Oguzhan Sahinkaya, and Mr. Bunyamin Sarioglu. While the consideration to be received by MOICML and Erkunt Traktör remains unchanged at Turkish Lira 1,00,000 (Rs. 2,13,000), the buyers will also infuse USD 10 million (₹95 crore) as part of the revised terms.
The disclosure was made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Other details provided in the previous letter dated April 10, 2026, remain unchanged. The intimation was uploaded on the company's website and submitted to the National Stock Exchange of India Limited and BSE Limited.
Transaction Details
The following table summarizes the key parties, their roles, and the corresponding consideration or infusion amounts under the revised terms:
| Party | Role | Consideration / Infusion |
|---|---|---|
| MOICML and Erkunt Traktor | Seller | Turkish Lira 1,00,000 (~Rs. 2,13,000) |
| MOICML | Infusion | Turkish Lira 2.26 billion (~₹471 crore) |
| Buyers (Hisarlar, Sahinkaya, Sarioglu) | Infusion | USD 10 million (~₹95 crore) |
The closing of the transaction is anticipated by August 15, 2026. The revised terms were executed to facilitate the extinguishment of external debt and ensure business continuity funding until the deal is finalized.
Historical Stock Returns for Mahindra & Mahindra
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.95% | +3.00% | +2.72% | -14.53% | -1.72% | +302.28% |
How will the increased infusion of Turkish Lira 2.26 billion impact Mahindra & Mahindra's financials in the short term?
What are the potential risks or challenges associated with completing the transaction by August 15, 2026?
How might this divestment affect Mahindra & Mahindra's strategic focus on other markets or business segments?






























